2 studies found for:    22837373 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
Conditions: Coronary Artery Disease;   Percutaneous Coronary Intervention
Intervention: Drug: cilostazol 100mg bid or clopidogrel 150-mg daily
2 Completed Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
Condition: Myocardial Infarction
Interventions: Drug: cilostazol;   Drug: clopidogrel (Plavix);   Genetic: CYP2C19;   Drug: aspirin (Acetylsalicylic acid)

Indicates status has not been verified in more than two years